CELL THERAPY CATAPULT LIMITED

Projekt → HEDGE-A: High cell density engineering for the production of recombinant adeno-associated virus (rAAV). HEDGE-A will address one of the current main challenges of biopharmaceutical production: The scalability of the recombinant adeno… Beitrag ansehen → Projekt → The GEne Therapy INnovation Training Network Gene therapy has transitioned from a distant hope to reality. To date 3 rAAV gene therapies are approved in the EU, >30 phase III… Beitrag ansehen → Projekt → A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing system Aim: The NANO-ENGINE project aims to develop a first-in-class, DNA-based, non-viral, targeted in vivo cell programming technology… Beitrag ansehen → Projekt → Modular Targeted Nanoplatform for Immune Cell Regulation and Therapy Cancer is a major cause of disability and mortality worldwide. The striking rise of immunotherapies has transformed the way we pr… Beitrag ansehen → Projekt → The critical shift to single-cell formats in functional analyses of living cells The incredible potential of cell and immune therapy (CIT) is limited by technical challenges related to the standard analysis of… Beitrag ansehen → Projekt → Synthetic Chimeric Antigen Receptors: Hijacking Nitrenium Ions for Targeting, Therapy and Safety of Next Generation T Cell Therapy Chimeric antigen receptor (CAR) T cell therapy is a promising approach for cancer treatment with remarkable clinical outcomes. CA… Beitrag ansehen →